First Patient Successfully Implanted with Heart Valve Replacement Device

French company Kephalios has successfully implanted a new adjustable device to repair a heart valve defect in a human patient for the first time.

The first of five patients in a clinical trial at the Vienna General Hospital has received an implant designed to repair mitral valve regurgitation. This disease causes the mitral valve to not close properly when the heart pumps, leading to some blood leaking back from the left ventricle to the left atrium (which are separated by the mitral valve)…